Rho GTPase-mediated pathways in mature CD4+ T cells.

Abstract:

:Effective immune responses require the appropriate activation and differentiation of peripheral CD4(+) T cells. These processes need to be followed by the timely elimination of the responding T cells in order to restore T cell homeostasis. Defects in the appropriate regulation of T cell activation, expansion, and survival underlie the pathogenesis of many autoimmune disorders including SLE. The molecular machinery employed by T cells to properly control these processes and prevent the onset of autoimmunity has not been fully elucidated. Rho GTPases (which include the Rac, Cdc42, and Rho subfamilies) are molecular switches that control a wide range of cellular processes. Their fundamental role in biology is due to their ability to regulate both cytoskeletal dynamics and a large number of signal transduction pathways. Activation of Rho GTPases is now recognized as a key event in the coordination of immune responses and, particularly, in the activation of T cells. In this review, we will first provide an overview of the role of Rho GTPase-mediated pathways in mature CD4(+) T cells and then we will discuss recent studies, which suggest that deregulation of these pathways may play a role in the pathogenesis of SLE.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Pernis AB

doi

10.1016/j.autrev.2008.07.044

subject

Has Abstract

pub_date

2009-01-01 00:00:00

pages

199-203

issue

3

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(08)00157-2

journal_volume

8

pub_type

杂志文章,评审
  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholip

    abstract::Autoimmune diseases are a complex set of diseases characterized by immune system activation and, although many progresses have been done in the last 15years, several unmet needs in the management of these patients may be still identified. Recently, a panel of international Experts, divided in different working groups ...

    journal_title:Autoimmunity reviews

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1016/j.autrev.2017.07.012

    authors: Giacomelli R,Afeltra A,Alunno A,Baldini C,Bartoloni-Bocci E,Berardicurti O,Carubbi F,Cauli A,Cervera R,Ciccia F,Cipriani P,Conti F,De Vita S,Di Benedetto P,Doria A,Drosos AA,Favalli EG,Gandolfo S,Gatto M,Grembiale R

    更新日期:2017-09-01 00:00:00

  • Microscopic polyangiitis: Clinical presentation.

    abstract::Microscopic polyangiitis (MPA) is a member of the family of ANCA-associated vasculitides. Its characteristic histology shows a necrotizing small vessel vasculitis with little or absent immune deposits (pauci-immune vasculitis). In Western countries MPA shows a lower prevalence than Wegener's disease, it affects more m...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.07.009

    authors: Villiger PM,Guillevin L

    更新日期:2010-10-01 00:00:00

  • Polyarteritis nodosa: A contemporary overview.

    abstract::Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis predominantly targeting medium-sized arteries. PAN is a rare form of vasculitis, and the precise frequency of this disease is difficult to determine. The major environmental factor associated with PAN is HBV infection. The pathogenesis of "idiopathic PAN"...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.02.015

    authors: De Virgilio A,Greco A,Magliulo G,Gallo A,Ruoppolo G,Conte M,Martellucci S,de Vincentiis M

    更新日期:2016-06-01 00:00:00

  • Stress as a trigger of autoimmune disease.

    abstract::The etiology of autoimmune diseases is multifactorial: genetic, environmental, hormonal, and immunological factors are all considered important in their development. Nevertheless, the onset of at least 50% of autoimmune disorders has been attributed to "unknown trigger factors". Physical and psychological stress has b...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.11.007

    authors: Stojanovich L,Marisavljevich D

    更新日期:2008-01-01 00:00:00

  • Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets.

    abstract::Rheumatoid Arthritis (RA) is a complex systemic autoimmune disease in which various cell types are involved. Among them, neutrophils have been recognized as important players in the onset and the progression of RA. The pathogenic role of neutrophils in RA lies in the alteration of several processes, including increase...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.06.006

    authors: Cecchi I,Arias de la Rosa I,Menegatti E,Roccatello D,Collantes-Estevez E,Lopez-Pedrera C,Barbarroja N

    更新日期:2018-11-01 00:00:00

  • Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis.

    abstract::Autoimmune responses and inflammation are involved in the excess cardiovascular risk observed in patients with systemic inflammatory diseases. Autoimmune myocarditis is a presentation of an inflammatory reaction of the heart during the course of autoimmune disorders, with most cases seen in systemic lupus erythematosu...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.05.005

    authors: Mavrogeni S,Dimitroulas T,Kitas GD

    更新日期:2012-12-01 00:00:00

  • Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura?

    abstract::Henoch-Schönlein purpura is the most common systemic vasculitis in childhood, characterized by the presence of immunoglobulin A deposits in the small vessels of skin, gastrointestinal tube, joints and kidneys. Although there have been great efforts made in elucidating its pathogenic mechanisms, Henoch-Schönlein purpur...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.04.003

    authors: Rigante D,Castellazzi L,Bosco A,Esposito S

    更新日期:2013-08-01 00:00:00

  • Coronary involvement in Takayasu's arteritis.

    abstract::Coronary involvement may appear in up to a third of patients with Takayasu's arteritis. This affliction may have a dominant impact on the clinical manifestations of the patient. Occlusion of the ostia of the left main coronary artery and of proximal segments of the coronary arteries is the most frequent finding of the...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.04.001

    authors: Rav-Acha M,Plot L,Peled N,Amital H

    更新日期:2007-09-01 00:00:00

  • B-cells and mixed cryoglobulinemia.

    abstract::Mixed cryoglobulinemia (MC) is a systemic small-vessel vasculitis; B-cell expansion is the biological substrate of the disease. It can be regarded as benign lymphoproliferative condition that may evolve to frank lymphoma. HCV infection is the main causative factor of MC, as well as of other overlapping disorders, thro...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.02.019

    authors: Ferri C,Antonelli A,Mascia MT,Sebastiani M,Fallahi P,Ferrari D,Giunti M,Pileri SA,Zignego AL

    更新日期:2007-12-01 00:00:00

  • Mechanotransduction and epigenetic control in autoimmune diseases.

    abstract::Differentiation of epithelial cells is required to define tissue architecture and appropriate function of these cells is associated with a specific pattern of gene expression. DNA methylation, post-translational modification of histones and chromatin remodeling are nuclear mechanisms implicated in epigenetic control o...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.09.022

    authors: González S,Aguilera S,Urzúa U,Quest AF,Molina C,Alliende C,Hermoso M,González MJ

    更新日期:2011-01-01 00:00:00

  • Does seronegative antiphospholipid syndrome really exist?

    abstract::The diagnosis of seronegative (SN-) antiphospholipid syndrome (APS) has been suggested for patients with clinical manifestations indicative of APS but with persistently negative results in the commonly used assays to detect anti-cardiolipin (aCL) antibodies, anti-β2 Glycoprotein I antibodies (aβ2GPI), and lupus antico...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.10.017

    authors: Cervera R,Conti F,Doria A,Iaccarino L,Valesini G

    更新日期:2012-06-01 00:00:00

  • Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group Registry.

    abstract:OBJECTIVE:To investigate differences between childhood (cPAN)- and adult-onset polyarteritis nodosa (aPAN) patients. METHODS:cPAN patients' clinical findings at onset and outcomes were compared to those of aPAN patients from the French Vasculitis Study Group registry matched for year of enrollment and initial systemic...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.08.001

    authors: Iudici M,Quartier P,Pagnoux C,Merlin E,Agard C,Aouba A,Roblot P,Cohen P,Terrier B,Mouthon L,Guillevin L,Puéchal X,French Vasculitis Study Group.

    更新日期:2018-10-01 00:00:00

  • Treatment of Raynaud's phenomenon.

    abstract::Raynaud's phenomenon is an episodic vasospasm of the peripheral arteries, causing pallor followed by cyanosis and redness with pain and sometimes paraesthesia, and, rarely, ulceration of the fingers and toes. Primary or idiopathic Raynaud's phenomenon (Raynaud's disease) occurs without an underlying disease. Secondary...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.002

    authors: García-Carrasco M,Jiménez-Hernández M,Escárcega RO,Mendoza-Pinto C,Pardo-Santos R,Levy R,Maldonado CG,Chávez GP,Cervera R

    更新日期:2008-10-01 00:00:00

  • Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.

    abstract::A few scores predicting the short-term risk of mortality in Systemic sclerosis (SSc) have been reported to date. Our study aimed to create a predictive 15-year all-cause mortality score at the time of the diagnosis of SSc. The study was based on the Spanish Scleroderma Registry (RESCLE). The cohort was split up in der...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102507

    authors: Rubio-Rivas M,Corbella X,Guillén-Del-Castillo A,Tolosa Vilella C,Colunga Argüelles D,Argibay A,Vargas Hitos JA,Todolí Parra JA,González-Echávarri C,Ortego-Centeno N,Trapiella Martínez L,Rodríguez Carballeira M,Marín Ballvé A,Pl

    更新日期:2020-05-01 00:00:00

  • The geoepidemiology of autoimmune intestinal diseases.

    abstract::Inflammatory bowel diseases (IBD) are chronic diseases of the intestinal tract which principally are composed of ulcerative colitis (UC) and Crohn's disease (CD). The prevalence and incidence of both forms of IBD have historically been higher in developed countries with decreasing North-South gradient. However, more r...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.008

    authors: Logan I,Bowlus CL

    更新日期:2010-03-01 00:00:00

  • How I treat patients with systemic sclerosis in clinical practice.

    abstract::Systemic sclerosis (SSc) or scleroderma is a disorder of the connective tissue affecting the skin, and it is often associated with visceral involvement. The predominant pathological features of SSc are autoimmunity, vasculopathy, and fibrosis. Progressive fibrosis is associated with changes in the microcirculation of ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.07.018

    authors: Rossi D,Zanatta E,Marson P,Sciascia S,Polito P,Roccatello D,Cozzi F

    更新日期:2017-10-01 00:00:00

  • New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis.

    abstract::Antimalarials have been an effective and safe treatment for autoimmune rheumatic diseases such as systemic lupus erythematosus for more than a hundred years. There are surprisingly few reports of hydroxychloroquine use in the systemic vasculitides. Hydroxychloroquine has antithrombotic, cardiovascular, antimicrobial a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.01.016

    authors: Casian A,Sangle SR,D'Cruz DP

    更新日期:2018-07-01 00:00:00

  • Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions.

    abstract::Regulatory T cells (Tregs) are central to the maintenance of self-tolerance and tissue homeostasis. Markers commonly used to define human Tregs in the research setting include high expression of CD25, FOXP3 positivity and low expression/negativity for CD127. Many other markers have been proposed, but none unequivocall...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.10.012

    authors: Grant CR,Liberal R,Mieli-Vergani G,Vergani D,Longhi MS

    更新日期:2015-02-01 00:00:00

  • Adaptive immune regulation in autoimmune diabetes.

    abstract::Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the loss of insulin-producing pancreatic β-cells. The pathogenesis of T1D is complex and multifactorial and involves a genetic susceptibility that predisposes to abnormal immune responses in the presence of ill-defined environmental insults to the ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.11.008

    authors: Ferretti C,La Cava A

    更新日期:2016-03-01 00:00:00

  • Diagnosis and classification of pernicious anemia.

    abstract::Pernicious anemia (PA) is a complex disorder consisting of hematological, gastric and immunological alterations. Diagnosis of PA relies on histologically proven atrophic body gastritis, peripheral blood examination showing megaloblastic anemia with hypersegmented neutrophils, cobalamin deficiency and antibodies to int...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.01.042

    authors: Bizzaro N,Antico A

    更新日期:2014-04-01 00:00:00

  • The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials.

    abstract::To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome (pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of clinical involvements (glandular/extraglandular involvement), to the lack of correlation between symptoms of dryness and glandular function ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2018.12.008

    authors: Felten R,Scher F,Sibilia J,Gottenberg JE,Arnaud L

    更新日期:2019-06-01 00:00:00

  • Risk of scleroderma according to the type of immune checkpoint inhibitors.

    abstract:INTRODUCTION:Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Among them, ICIs-induced systemic sclerosis (SSc) is poorly known. METHODS:To better characterize this irAE, our comprehensive approach combined the description of ICIs-induced scleroderma cases, the systematic ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102596

    authors: Terrier B,Humbert S,Preta LH,Delage L,Razanamahery J,Laurent-Roussel S,Mestiri R,Beaudeau L,Legendre P,Goupil F,Hadjadj J,Stolzenberg MC,Treluyer JM,Westeel V,Valnet-Rabier MB,Wislez M,Mouthon L,Chouchana L

    更新日期:2020-08-01 00:00:00

  • Cellular players in angiogenesis during the course of systemic sclerosis.

    abstract::Vascular endothelial injury in Systemic Sclerosis (SSc) leads to pathological changes in the blood vessels that adversely impact the physiology of many organs, resulting in chronic tissue ischemia. The response to hypoxia induces complex cellular and molecular mechanisms in the attempt to recover endothelial cell func...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.016

    authors: Cipriani P,Marrelli A,Liakouli V,Di Benedetto P,Giacomelli R

    更新日期:2011-08-01 00:00:00

  • Kawasaki disease: current aspects on aetiopathogenesis and therapeutic management.

    abstract::Kawasaki disease (KD) is a vasculitis that affects mainly children of 6 months to 4 years old. It is important to be early recognised so as to limit the inflammatory cascade that may lead to aneurysmatic dilatations of coronary arteries. The causative agent of KD has not been still indentified and the aetiopathogeneti...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.005

    authors: Alexoudi I,Kanakis M,Kapsimali V,Vaiopoulos G

    更新日期:2011-07-01 00:00:00

  • The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity.

    abstract::IgG4-related disease is a distinct clinical entity, whose characteristic features are the following; Serum IgG4 is prominently elevated, IgG4-positive plasma cells infiltrate in involved tissues, various mass-forming lesions with fibrosis develop in a timely and spatial manner and the response to corticosteroids is pr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.05.003

    authors: Takahashi H,Yamamoto M,Suzuki C,Naishiro Y,Shinomura Y,Imai K

    更新日期:2010-07-01 00:00:00

  • A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab.

    abstract::Approximately 500 treatment recalcitrant pemphigus vulgaris patients have been treated with rituximab. They were treated according to the lymphoma protocol (N=224) or rheumatoid arthritis protocol (RAP) (N=209) patients. Others were treated with modifications or combinations of the two. The mean duration of follow-up ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.12.002

    authors: Ahmed AR,Shetty S

    更新日期:2015-04-01 00:00:00

  • B cells in systemic sclerosis: a possible target for therapy.

    abstract::Systemic sclerosis (SSc) is an autoimmune disease characterized by excessive extracellular matrix (ECM) deposition in the skin and other visceral organs and it is associated with immune activation characterized by autoantibody production, release of various cytokines and T-lymphocyte activation. Several recent lines o...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.013

    authors: Bosello S,De Luca G,Tolusso B,Lama G,Angelucci C,Sica G,Ferraccioli G

    更新日期:2011-08-01 00:00:00

  • The effect of non-TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis.

    abstract::Inflammatory arthritides are chronic diseases characterised by an increase in cardiovascular risk, largely attributable to the synergy between high-grade systemic inflammation and an elevated prevalence of traditional cardiovascular risk factors. Amongst the latter, insulin resistance and type 2 diabetes (T2D) play a ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.11.030

    authors: Ursini F,Russo E,Ruscitti P,Giacomelli R,De Sarro G

    更新日期:2018-04-01 00:00:00

  • Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk?

    abstract::In patients with systemic auto-immune inflammatory rheumatic diseases (AIIRD) like rheumatoid arthritis the prevalence of cardiovascular disease (CVD) is increased. In the pathogenesis of AIIRD and atherosclerosis many similarities can be found in the process underlying CVD. Accumulation of inflammatory cells, in part...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.002

    authors: Jager NA,Teteloshvili N,Zeebregts CJ,Westra J,Bijl M

    更新日期:2012-07-01 00:00:00

  • Common variable immunodeficiency and autoimmunity--an inconvenient truth.

    abstract::Coexisting morbidities in CVID include bronchiectasis, autoimmunity and malignancies. The incidence of autoimmune disease in CVID patients may approach 20% of cases. The most common autoimmune disease found in CVID patients is autoimmune cytopenia, but rheumatoid arthritis, lupus, and now primary biliary cirrhosis hav...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.04.006

    authors: Xiao X,Miao Q,Chang C,Gershwin ME,Ma X

    更新日期:2014-08-01 00:00:00